 |
Volcano Announces First Quarter Results
May 2, 2013
|
30.7 KB |
|
| |
SAN DIEGO, May 2, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the first quarter of 2013.
For the quarter ended March 31, 2013, Volcano repo...
|
|
Volcano Corporation Schedules First Quarter Conference Call, Webcast
Apr 22, 2013
|
9.1 KB |
|
| |
SAN DIEGO, April 22, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the first quarter of fiscal 2013 on Thursday, May 2...
|
|
Volcano Announces Launch of Valet® Microcatheter in the United States and Europe
Mar 14, 2013
|
11.9 KB |
|
| |
SAN DIEGO, March 14, 2013 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announces the launch of the Valet® microcatheter in the United States and Europe.
Valet is ...
|
|
Volcano Corporation Announces Presentations At Upcoming Investor Conferences
Mar 4, 2013
|
10.2 KB |
|
| |
SAN DIEGO, March 4, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in two upcoming investor conferences.
On Tuesday, March 12, t...
|
|
Volcano Corporation Announces Webcast Of March Seventh Analyst Day
Feb 26, 2013
|
8.9 KB |
|
| |
SAN DIEGO, Feb. 26, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, will hold its 2013 Analyst Day on Thursday, March 7, at the NASDAQ MarketSite in New York City.
A web...
|
|
Volcano Corporation Provides Additional Guidance For 2013
Feb 21, 2013
|
15.5 KB |
|
| |
SAN DIEGO, Feb. 21, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, is providing additional guidance for 2013 on an as reported basis to augment guidance provided on a constant ...
|
|
Volcano Announces Record Fourth Quarter Revenues
Feb 21, 2013
|
34.7 KB |
|
| |
SAN DIEGO, Feb. 21, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the fourth quarter of 2012.
For the quarter ended December 31, 2012, Volcan...
|
|
Volcano Corporation Schedules Fourth Quarter Conference Call, Webcast
Feb 11, 2013
|
9.1 KB |
|
| |
SAN DIEGO, Feb. 11, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the fourth quarter of fiscal 2012 on Thursday, Febru...
|
|
Volcano Announces New iPad Teaching Application for Its Recently-Released Visions® PV .035 Digital IVUS Catheter
Feb 1, 2013
|
11.6 KB |
|
| |
SAN DIEGO, Feb. 1, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it has a new interactive educational tool to facilitate learning about IVUS-guided intervention...
|
|
Volcano Corporation Announces Record Preliminary Fourth Quarter 2012 Revenues
Jan 7, 2013
|
17.4 KB |
|
| |
SAN DIEGO, Jan. 7, 2013 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it expects total revenues for the fourth quarter of 2012 will be approximately $102.5 million,...
|
|
Volcano Corporation Presentation At J.P. Morgan Conference To Be Webcast
Dec 27, 2012
|
9.1 KB |
|
| |
SAN DIEGO, Dec. 27, 2012 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 31st Annual J.P. Morgan Healthcare Conference on Tuesday, Jan...
|
|
Volcano Corporation Prices Offering Of $400 Million 1.75% Convertible Senior Notes Due 2017
Dec 5, 2012
|
13.9 KB |
|
| |
SAN DIEGO, Dec. 5, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) today announced the pricing of its public offering of $400 million aggregate principal amount of 1.75% convertible senior notes due December 1, 2017 registered under the Securities Act of 1933, as amended. Prior to August 7, 2017, the notes will be convertible only upon cert...
|
|
Volcano Corporation To Offer $350 Million Convertible Senior Notes Due 2017
Dec 3, 2012
|
13.2 KB |
|
| |
SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC) today announced its intention to offer, subject to market and other conditions, $350 million principal amount of convertible senior notes due December 1, 2017 in an offering registered under the Securities Act of 1933, as amended. Prior to August 7, 2017, the notes will be c...
|
|
Volcano Corporation Announces Agreement To Acquire Crux Biomedical
Dec 3, 2012
|
14.4 KB |
|
| |
SAN DIEGO, Dec. 3, 2012 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today it has signed an agreement to acquire Crux Biomedical, a privately-held company that has developed ...
|
|
Volcano Corporation Signs Agreement to Acquire Sync-Rx Ltd.
Nov 23, 2012
|
12.7 KB |
|
| |
SAN DIEGO, Nov. 23, 2012 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it has entered into a definitive agreement to acquire Sync-Rx Ltd., a privately-held com...
|
|
Volcano Corporation Presentation At Piper Jaffray Conference To Be Webcast
Nov 16, 2012
|
9.1 KB |
|
| |
SAN DIEGO, Nov. 16, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, said today that it will be participating in the 24th Annual Piper Jaffray Healthcare Conference on Tuesday, N...
|
|
Largest Prospective Study Shows IVUS-Guided Stent Placement Improves Patient Outcomes with Current Generation of Stents
Nov 14, 2012
|
13.2 KB |
|
| |
SAN DIEGO, Nov. 14, 2012 /PRNewswire/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that results from the largest study of its kind show that stent procedures guided by intravas...
|
|
Volcano Corporation Reports Third Quarter 2012 Results
Nov 6, 2012
|
29.6 KB |
|
| |
SAN DIEGO, Nov. 6, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today reported results for the third quarter of 2012.
For the quarter ended September 30, 2012, Volcano...
|
|
Volcano Corporation Schedules Third Quarter Conference Call, Webcast
Oct 25, 2012
|
9.1 KB |
|
| |
SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will report its operating results for the third quarter of fiscal 2012 on Tuesday, Novembe...
|
|
Volcano Announces Previous St. Jude Medical Products Infringe Volcano Patent and Jury Verdicts in Patent Trials with St. Jude Medical
Oct 25, 2012
|
11.2 KB |
|
| |
SAN DIEGO, Oct. 25, 2012 /PRNewswire/ -- Volcano Corporation (NASDAQ: VOLC), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that St. Jude Medical agreed that previous versions of its PressureWire® products infri...
|
|
|
